An observational study in Acne and Postinflammatory Hyperpigmentation, sponsored by Cosmetique Active International. Completed at 1 site in United Arab Emirates. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-11-01.
Sponsored by Cosmetique Active International · Observational
Acne is a chronic, inflammatory skin condition. It may cause scars and post-inflammatory hyperpigmentation (PIHP). PIHP frequently affects individuals with a phototype of IV or above.[1] PIHP is worsened by UV radiation, lasts for years and impacts the individual well-being.[2, 3] In an observational study, 1785 adults with a phototype ranging from IV to VI with acne and PIHP applied daily for 2 months a dermocosmetic and a tainted sunscreen product (DC, Effaclar® Duo (+); SS, Anthelios® Shaka Fluide SPF 50+, SS; both La Roche-Posay Laboratoire Dermatologique, France.
102 studies on the registry are indexed under Hyperpigmentation; 20 are open to participants now.
This study's enrollment of 1,785 is above the median of 80 across 11 observational studies indexed under Hyperpigmentation.
Browse Hyperpigmentation studies →Cosmetique Active International is the lead sponsor of 54 studies on the registry; 13 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Adult subjects with mild to moderate acne, post-inflammatory hyperpigmentation and of any phototype were suitable for this study.
Exclusion Criteria:
Topical application once daily for 2 months
Also known as: Sun screen
seborrhoea level
visual analog scale scale 0=none to 10= very severe
Time frame: baseline
seborrhoea level
visual analog scale 0=none to 10= very severe
Time frame: Month 2
acne severity
GEA (Global evaluation of acne) scale 0=none to 5=very severe
Time frame: baseline
acne severity
GEA (Global evaluation of acne) scale 0=none to 5=very severe
Time frame: Month 2
PAHPI: post-acne hyperpigmentation index
post-acne hyperpigmentation index from \<3mm to \>10mm
Time frame: baseline
PAHPI: post-acne hyperpigmentation index
post-acne hyperpigmentation index from \<3mm to \>10mm
Time frame: Month 2
inflammatory lesions
lesion count
Time frame: baseline
inflammatory lesions
lesion count
Time frame: Month 2
non-inflammatory lesions
lesion count
Time frame: baseline
non-inflammatory lesions
lesion count
Time frame: Month 2
Investigator satisfaction acne
visual analog scale from very unsatified=0 to very satisfied=5
Time frame: Month 2
Investigator satisfaction
visual analog scale from very unsatified=0 to very satisfied=5
Time frame: Month 2
Patient satisfaction acne
visual analog scale from very unsatified=0 to very satisfied=5
Time frame: Month 2
Patient satisfaction PAHPI
visual analog scale from very unsatified=0 to very satisfied=5
Time frame: Month 2
Patient: Skin quality
visual analog scale from very unsatified=0 to very satisfied=5
Time frame: Month 2
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Oct 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Cosmetique Active International